Congresos

Título Añoorden ascendente
Derivados dendríticos con nucleo de Boltorn como agentes de transfección 2016
Exosomes from placental MSCs as vehicles for the Na/I symporter (hNIS): A new anitumoral therapy 2016
Human placenta-derived multipotent mesenchymal stem cells show evidence of unique features that make them ideal candidates for cancer cell therapies. 2015
Simultaneous tracking of Bone Marrow-MSCs migration towards different pathologies. Promise for cancer cell therapies. 2015
Gastric Cancer circulating exosomes: Detection and relevance for the disease progression. 2015
Nanoparticle modification of adenoviruses for CAR-negative cells 2015
Molecular imaging of the mesenchymal stem cells migratory properties towards different pathologies. 2015
Mesenchymal Stem Cells as Hollow Gold Nanoparticles vectors in tumor treatments 2015
Use of viral vectors and nanoparticles for stem cell imaging. Nanoparticle modification of adenoviruses for car negative cells 2014
Use of viral vectors and nanoparticles for stem cell imaging. Nanoparticle modification of adenoviruses for car negative cells 2014
Molecular imaging of the mesenchymal stem cells migratory properties towards different pathologies. 2013
Differences between methodological approaches and animal species on the whole liver decellularization process for tissue engineering 2013
Influence of pamam dendrimers of the bacterial and celular growth. Changes in mesenchymal stem cells 2013
Bis-MPA dendritic derivatives as gene delivery agents 2013
Human placenta-derived multipotent mesenchymal stem cells exhibit unique features that make them ideal candidates for cancer and wound healing therapies 2013
Bis-MPA dendritic derivatives as gene delivery agents 2013
Human placenta-derived multipotent mesenchymal stem cells exhibit unique features that make them ideal candidates for cancer and wound healing therapies 2013
Use of gold nanoparticles to enhance the MSCs adenoviral infection for cell therapies 2013
Hollow Gold Nanoparticles as tumor treatment 2013
bis-MPA DERIVATIVES AS BUILDING BLOCKS FOR GENE DELIVERY 2012

Páginas